LONDON, UK – July 08, 2013 – BCSI, a leading medical device provider and Planer PLC, specialists in controlled temperature environments for medical labs and clinics, announced a partnership today during the annual meeting of European Society of Human Reproduction and Embryology (ESHRE). The two companies will collaborate on bringing new technologies to market to address current issues in pH monitoring for Invitro Fertilizaton (IVF) and other uses.

“We are transferring our years of experience in blood storage to other areas where our technology can have a big impact,” said Russ Aldrich, CEO, BCSI.  “Because of that experience we are seeing early positive results with this technology in areas such as assisted reproduction.”

“We are excited and proud about the use of our bench-top incubators for assisted reproductive procedures such as IVF,” said Geoffrey Planer, CEO, Planer.  “Partnering with BCSI ensures that together we will continue to advance the overall effort for better outcomes for families.”

About Planer

Planer PPC specializes in the control of temperature and other parameters to help customers achieve scientific breakthroughs in biology, medicine and industry. Planer pioneered the development and use of many controlled temperature products as well as monitoring and logging of other key lab parameters. Planer holds a number of patents and has received the Queen’s Award for Technology and awards from the DTI for Innovation and Good Practice in Microelectronics.

Planer, and the Planer logo are trademarks of Planer, PLC. BCSI, SAFE Sens and the BCSI logo are trademarks of BCSI. All other names or product names mentioned in this release are trademarks or registered trademarks of their respective companies.